TRANSKARYOTIC THERAPIES INC
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Insider transactions
SEC Form 4 · most recent0 acquisitions1 disposalsnet −18,167 shares · last 1
| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Gilbert Walter PhdDirector | Jul 27, 2005 | D | 18,167 | $37.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Results of operationsMay 5, 2005
- Entered a material agreement · Modified shareholder rights · Director / officer changeApr 27, 2005
- Entered a material agreementApr 15, 2005
- Entered a material agreementMar 30, 2005
- Results of operationsFeb 23, 2005
- Other material eventJan 19, 2005
- Results of operationsJan 12, 2005
- Results of operationsNov 9, 2004
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AAMENDMENTFeb 14, 2006
- SC 13G/AFeb 13, 2006
- SC 13GFeb 10, 2006
- 4Jul 29, 2005
- 4Jul 29, 2005
- 4Jul 29, 2005
- 4Jul 29, 2005
- 4Jul 29, 2005
- 4Jul 29, 2005
- 4Jul 29, 2005
- 4Jul 29, 2005
- 4Jul 29, 2005
- 15-12GTRANSKARYOTIC THERAPIES, INC.Jul 28, 2005
- DEFA14ATRANSKARYOTIC THERAPIES, INC.Jul 22, 2005
- SC 13DJul 21, 2005
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.